SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Novartis -- Ignore unavailable to you. Want to Upgrade?

To: Starlight who wrote (249)1/22/1999 10:51:00 PM
From: Stan Pruss  Read Replies (1) | Respond to of 296
 
What happened today? My quote says down to $95. Lots of press releases, anyone have time to read them?



To: Starlight who wrote (249)2/1/2000 7:39:00 AM
From: Steve Becker  Read Replies (2) | Respond to of 296
 
Novartis to list on the New York Stock Exchange:
"a move widely viewed as a precursor to an acquisition or merger, the Wall Street Journal reported."

dailynews.yahoo.com

With the stock now at a post merger low I hope this is a buying opportunity.
Just imagine, after Novartis is on the NYSE fund managers that excluded the stock might now purchase it. Perhaps it'll even be added to an index or two someday.

Steve


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News